HNRNPA1 and prostate carcinoma: In prostate cancer cells, overexpression of hnRNPA1 was associated with increased levels of the androgen receptor splice variant AR-V7 [36], which is constitutively active even in the absence of androgens and has been implicated in the development of the castration-resistant phenotype [15].